Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Enforces New Dietary Ingredient Notification Requirement With Import Alerts

This article was originally published in The Tan Sheet

Executive Summary

Supplement industry stakeholders say FDA is detaining without inspection imported products previously allowed entry, including synthetic botanicals and ingredients it asserts should be covered in NDI notifications. Firms can reduce their vulnerability by reviewing alerts before contracting with suppliers.


Related Content

CRN Asks FDA To Stop Enforcement Against Synthetic Botanicals
FDA Revision Of NDI Draft Guidance Starts With Grandfathered List





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts